TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

MALVERN, Pa., Aug. 31, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that Roberto Cuca, Chief Operating Officer and Chief Financial Officer, will step down from the role effective today.

“On behalf of the Board and management team, I would like to thank Roberto for his many contributions to TELA Bio over the past five years,” said Heather Getz, Chief Executive Officer of TELA Bio. “Roberto has been instrumental in helping us scale operations in support of the Company’s long-term growth aspirations. We are deeply grateful for his commitment to the organization, and we wish him all the best in his future endeavors.”